Published in Clin Chem on November 01, 1970
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26
Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet (1984) 2.10
Syndrome associated with the abuse of analgesics. Ann Intern Med (1968) 1.82
Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int (1984) 1.33
Association between hydrocarbon exposure and glomerulonephritis. An appraisal of the evidence. Nephron (1983) 1.24
Clinimetrics in nephrology. Nephron (1986) 1.18
Cadaver kidney transplants. Transplantation (1967) 1.02
Analgesic nephropathy. A clinicopathologic study using electron microscopy. Am J Med (1971) 1.02
Improvements in drug prescription labels for patients with limited education or vision. Can Med Assoc J (1982) 1.01
Analgesic habits of 500 veterans: incidence and complications of abuse. Can Med Assoc J (1968) 1.01
Cerebral and pontine myelinolysis. Two cases with fluid and electrolyte imbalance and hypotension. J Neurol Sci (1973) 0.98
Hypernatremia, azotemia, and dehydration ue to high-protein tube feeding. Ann Intern Med (1968) 0.95
Glomerular injury in patients with neoplasia. Annu Rev Med (1976) 0.93
Hydrolysis of digoxin by acid. J Pharm Pharmacol (1977) 0.91
Left ventricular hypertrophy in end-stage renal disease. Nephron (1988) 0.90
Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron (1988) 0.88
Kidney transplantation and long-term dialysis. Am Heart J (1970) 0.88
Development of a health questionnaire specific for end-stage renal disease. Nephron (1989) 0.88
Analgesic nephropathy, 1972-76. Can Med Assoc J (1977) 0.87
Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis. Hum Mol Genet (1994) 0.87
Effect of some drugs on clinical laboratory values as determined by the Technicon SMA 12-60. Clin Chem (1972) 0.86
Hepatitis with Australia antigenemia following renal transplantation. Can Med Assoc J (1973) 0.86
Clinical significance of urinary LDH, alkaline phosphatase and other enzymes. Can Med Assoc J (1969) 0.86
Renal biopsy: current views and controversies. Nephron (1983) 0.84
Urolithiasis--a study of drinking water hardness and genetic factors. J Chronic Dis (1980) 0.84
Analgesic nephropathy in Canada: clinical syndrome, management, and outcome. Kidney Int (1978) 0.84
Persisting renal insufficiency after methoxyflurane anesthesia. Report of two cases and review of literature. Am J Med (1974) 0.83
Letter: Creatinine clearance and age. Lancet (1975) 0.83
The plasma phenolsulfonphthalein index (PSPI) of renal function: I. Theoretical considerations and investigative studies. Can Med Assoc J (1966) 0.83
Significance of a negative cross match in recipients with a wide spectrum of lymphocytotoxic antibodies. Transplantation (1971) 0.83
Biotransformation and elimination of digoxin with normal and minimal renal function. Clin Pharmacol Ther (1979) 0.83
Chronic pyelonephritis: relative incidence in transplant recipients. N Engl J Med (1966) 0.82
Hyperchloremic acidosis in early diagnosis of renal allograft rejection. Ann Intern Med (1969) 0.82
Urinary enzymes in benign and malignant urinary tract disorders: alkaline phosphatase and lactic acid dehydrogenase. Br J Urol (1967) 0.82
Comparison of infrared and wet chemical analysis of urinary tract calculi. Clin Chim Acta (1980) 0.81
Plasma digitalis-like factor(s) increase with salt loading. N Engl J Med (1983) 0.81
Human adenine phosphoribosyltransferase: characterization from subjects with a deficiency of enzyme activity. Biochem Genet (1983) 0.81
Development of lymphocytotoxic antibodies in hemodialysis patients. Vox Sang (1972) 0.80
Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase. Can Med Assoc J (1967) 0.80
Evidence for the nephrotoxicity of analgesics. Can Med Assoc J (1972) 0.80
Studies of digoxin dosage, kinetics and serum concentrations in renal failure and review of the literature. Nephron (1976) 0.80
Serum and urinary enzyme activity after renal infarction. Can Med Assoc J (1965) 0.80
Preservation of the dog kidney. J Surg Res (1968) 0.79
Symptoms in end-stage renal disease: dialysis v transplantation. Transplant Proc (1987) 0.79
Fluid and electrolyte complications of peritoneal dialysis. Choice of dialysis solutions. Ann Intern Med (1971) 0.79
Fractionation of tritiated digoxin and dihydrodigoxin with DEAE-sephadex LH-20. J Chromatogr (1976) 0.79
Kidney transplants: computer display of clinical and laboratory parameters. The first 100 days. Can Med Assoc J (1969) 0.79
Pediatric urolithiasis in the 1970s. J Urol (1980) 0.79
Declining incidence of analgesic nephropathy in Canada. Can Med Assoc J (1982) 0.78
The oxalate:phosphate ratio in urinary tract calculi by infrared revised analysis. Clin Chim Acta (1987) 0.78
Low-output left ventricular failure in end-stage renal disease. Am J Nephrol (1987) 0.78
First morning urine pH in the diagnosis of renal tubular acidosis with nephrolithiasis. Clin Nephrol (1994) 0.78
Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values. Gastroenterology (1966) 0.78
Letter: The clinical course of patients with analgesic nephropathy. Can Med Assoc J (1975) 0.77
Comparative value of lymphocyturia, serum, and urinary enzymes in the diagnosis of renal homograft rejection. Surg Forum (1965) 0.77
Plasma conjugated androgens in a dialysis-dependent male as immunoreactive digitalis-like factors. Clin Nephrol (1990) 0.77
Solitary intrarenal cyst: correctable cause of hypertension. Urology (1975) 0.77
Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults. Res Commun Chem Pathol Pharmacol (1985) 0.77
Erythromycin-cyclosporine interaction in renal transplant recipients. Transplantation (1987) 0.77
Higher values for digitalis-like factors with TDx Digoxin II. Clin Chem (1986) 0.76
Methemoglobin formation in analgesic nephropathy. Clin Pharmacol Ther (1974) 0.76
Congestive heart failure in dialysis patients. Arch Intern Med (1988) 0.76
Radiation nephritis following combined abdominal radiation and chemotherapy (bleomycin-vinblastine). Cancer (1978) 0.75
Occurrence of two cases of cryptococcosis within 3 months on the same general medical ward. Can Med Assoc J (1976) 0.75
Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? CMAJ (1992) 0.75
The plasma phenolsulfonphthalein index (PSPI) of renal function. II. Correlation with other parameters of renal function and indications for use. Can Med Assoc J (1966) 0.75
Drug metabolites and immunoassays. Clin Chem (1994) 0.75
Peritoneal dialysis solutions. Can Med Assoc J (1973) 0.75
Loading dose of digoxin in renal failure. Br J Clin Pharmacol (1980) 0.75
Toxic nephropathy after low-dose methoxyflurane anesthesia: drug interaction with secobarbital? Can Med Assoc J (1976) 0.75
Adrenocortical hyperfunction associated with bronchogenic carcinoma: report of five cases. Can Med Assoc J (1965) 0.75
Facing reality. CMAJ (1998) 0.75
Nephrolithiasis in rural practice. Can Med Assoc J (1980) 0.75
Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients. Clin Nephrol (1987) 0.75
Trace elements and hemodialysis. Nephron (1991) 0.75
Triamterene urolithiasis. Can Med Assoc J (1981) 0.75
The 131-I-hippurate renogram as a quantitative test of function in renal parenchymal disease. Nephron (1973) 0.75
Hemodialysis for methanol intoxication. Proc Clin Dial Transplant Forum (1977) 0.75
Evaluation of renal function without collection of urine. Ann Intern Med (1968) 0.75
Urine pigments after ingestion of phenacetin. Can J Physiol Pharmacol (1972) 0.75
Letter: Furosemide stimulation of peripheral renin in men and women. N Engl J Med (1976) 0.75
Interference by endogenous p-hydroxyphenylacetic acid with estimation of N-acetyl-p-aminophenol in urine by gas chromatography. J Pharm Pharmacol (1977) 0.75
Assay of inulin in tissue using anthrone. Clin Biochem (1975) 0.75
High-performance liquid chromatographic method for isolation of tritiated digoxin and metabolites in urine. J Chromatogr (1980) 0.75
Peripheral renin activity before and after furosemide in normotensives and hypertensives. Clin Invest Med (1980) 0.75
The plasma phenolsulfonphthalein index (pspi) of renal function. 3. Correlation with urinary PSP excretion in assessment of urological disorders. J Urol (1967) 0.75
Extraction of digoxin and its metabolites from urine and their separation by Sephadex LH-20 column chromatography. Clin Biochem (1976) 0.75
Prediction of immunoglobulins from patterns of cellulose acetate electrophoresis. Clin Chem (1969) 0.75
The sixty-minute plasma phenolsulfonphthalein concentration as a test of renal function. Am J Clin Pathol (1969) 0.75
Successful skin graft on renal allograft: report of a case. Can J Surg (1971) 0.75
A unique instance of canine renal homotransplantation with remission of rejection crisis and prolonged survival. Transplantation (1966) 0.75
Phenolsulfonphthalein (PSP) in assessment of renal function. JAMA (1967) 0.75
Methemoglobin formation in patients with renal disease associated with abuse of analgesics containing phenacetin. J Lab Clin Med (1971) 0.75
The effect of acetylsalicylic acid, caffeine, and codeine on the excretion of phenacetin metabolites. Can J Physiol Pharmacol (1972) 0.75
Characteristics of erythropoiesis following human renal homotransplantation. Transplant Proc (1971) 0.75
The place of phenosulfonphthalein (PSP) in the measurement of renal function. Am Heart J (1968) 0.75